Table 2.
Variables | Favorable prognosis | Poor prognosis | Total | P | |
---|---|---|---|---|---|
GCS score, n (%) | |||||
3‐8 | 22 (10.95) | 21 (61.80) | 43 (18.40) | H = 54.46 | <.001 |
9‐12 | 10 (4.98) | 4 (11.80) | 14 (6.00) | ||
13‐15 | 168 (83.58) | 9 (26.50) | 177 (75.60) | ||
Rebleeding or death 24 h after onset a , n (%) | |||||
None | 196 (99.49) | 32 (94.12) | 228 (98.70) | .054 | |
Rebleeding or death | 1 (0.51) | 2 (5.88) | 3 (1.30) | ||
HDL b , mmol/L, M(P25, P75) | 1.35 (1.15, 1.59) | 1.30 (1.10, 1.77) | 1.34 (1.14, 1.62) | z = 1.39 | .326 |
LDL, mmol/L, /M(P25, P75) | 3.14 ± 0.89 | 2.90 ± 0.99 | 3.11 (2.55,3.60) | t = 1.35 | .177 |
NLR c , | 7.04 (5.10, 11.62) | 11.20 (7.17, 17.44) | 7.37 (5.54, 12.31) | t′ = −3.68 | .001 |
PLR c , M(P25, P75) | 157.39 (111.90, 203.56) | 180.80 (122.00, 252.88) | 160.79 (112.30, 206.81) | t′ = −2.23 | .033 |
HR c , beats/min, | 81.51 ± 9.48 | 89.50 ± 16.79 | 82.67 ± 11.17 | t′ = −2.70 | .010 |
WBC count, | 13.89 ± 4.64 | 17.04 ± 4.74 | 14.34 ± 4.77 | t = −3.61 | <.001 |
PLT count, | 229.73 ± 56.97 | 227.48 ± 67.09 | 229.41 ± 58.35 | t = 0.20 | .838 |
NEUT, | 11.49 ± 4.48 | 14.65 ± 4.27 | 11.93 ± 4.58 | t = 3.79 | <.001 |
LC b , M(P25, P75) | 1.50 (1.10, 2.00) | 1.10 (0.90, 1.90) | 1.40 (1.10, 2.00) | z = 1.53 | .295 |
AST, U/L, | 26.61 ± 12.84 | 32.79 ± 15.09 | 27.50 ± 13.33 | t = −2.45 | .015 |
Albumin, g/L, | 42.85 ± 4.35 | 40.50 ± 6.06 | 42.51 ± 4.70 | t = 2.70 | .008 |
FBG c , mmol/L, | 7.02 ± 2.53 | 8.69 ± 3.39 | 7.22 ± 2.69 | t′ = −2.32 | .028 |
Abbreviations: AST, glutamic oxaloacetic transaminase; FBG, fasting blood‐glucose; GCS, Glasgow Coma Scale; HDL, high‐density lipoprotein; HR, heart rate; LC, lymphocyte count; LDL, low‐density lipoprotein; NEUT, neutrophil count; NLR, neutrophil‐lymphocyte ratio; PLR, platelet‐lymphocyte ratio; PLT, platelet; WBC, white blood cell.
Using Fisher test;
Using Mann‐Whitney U test;
Using t test.